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Abstract 
Stepwise regression building procedures are commonly used applied statistical tools, despite 
their well-known drawbacks. While many of their limitations have been widely discussed in the 
literature, other aspects of the use of individual statistical fit measures, especially in high-
dimensional stepwise regression settings, have not. Giving primacy to individual fit, as is done 
with p-values and R2, when group fit may be the larger concern, can lead to misguided decision 
making. One of the most consequential uses of stepwise regression is in health care, where these 
tools allocate hundreds of billions of dollars to health plans enrolling individuals with different 
predicted health care costs. The main goal of this “risk adjustment” system is to convey 
incentives to health plans such that they provide health care services fairly, a component of 
which is not to discriminate in access or care for persons or groups likely to be expensive. We 
address some specific limitations of p-values and R2 for high-dimensional stepwise regression in 
this policy problem through an illustrated example by additionally considering a group-level 
fairness metric.  
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1. INTRODUCTION 
Many statistics textbooks, including those in graduate-level statistical science and applied 
health courses, instruct students to perform stepwise regressions for practical data analyses. 
These methods have been deployed in the context of building prediction functions, where input 
variables are used to estimate outcomes, and effect estimation, where the parameter of interest is 
instead the effect of an exposure or intervention on the outcome. Stepwise procedures have 
varied flavors and may start with an empty or partial model adding variables, a full model with 
all variables followed by deletion steps, or some combination or these two processes (Efroymson 
1966; Draper and Smith 1966; Mantel 1970; Hocking 1976; Miller 2002; Sinisi and van der Laan 
2004). After each variable addition or deletion step, an evaluation metric is used to assess 
whether that step impacted fit. Metrics can include p-values, R2, F tests, and additional choices 
depending on the procedure.  
However, there are numerous widely discussed limitations of stepwise methods, such as 
misleadingly small p-values not adjusted to account for the iterative fitting and biased R2 
measures, among others (Hocking 1976; Harrell 2001). Post-selection inference is an active area 
of statistical methods research, but most off-the-shelf statistical software does not incorporate 
these advances. Despite cautioning applied researchers about the shortcomings of traditional 
stepwise procedures, they are commonly used in practice.  
One empirical prediction setting where stepwise regressions are currently applied is risk 
adjustment in health policy, which spans many areas, including public reporting, quality 
measurement, and payment models for health insurance plans. This paper focuses on the problem 
of stepwise regression building for the latter case, the prediction of payments to health plans, as a 
demonstrative example. We summarize how stepwise regression works in the context of plan 
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payment risk adjustment to predict individual spending as well as some central limitations of p-
values and R2 for high-dimensional prediction. We then consider aspects of “fairness” and 
implement a metric to assess fair predictions for individuals in vulnerable (i.e., 
undercompensated) groups. Groups, such as individuals with mental health and substance use 
disorders (MHSUD), are considered according to the means a health plan has at their disposal to 
discourage enrollment in their health plans and restrict health services. 
 
2. PROBLEMS WITH P-VALUES AND R2 IN STEPWISE REGRESSION FOR RISK 
ADJUSTMENT  
Risk adjustment in health plan payment as translated into a statistical estimation 
framework is a familiar, classical prediction question, which we define formally here. Consider a 
continuous spending outcome 	𝑌, a vector of demographic variables 𝑫 = (𝐷', 𝐷(,… , 𝐷+), and a 
vector of health variables 𝑯 = (𝐻', 𝐻(, … ,𝐻/). A typical risk adjustment model would be given 
by: 𝐸(𝑌|𝑫,𝑯) = 𝛼𝑫 + 𝛽𝑯, 
where 𝐸 represents an expectation, 𝐸(𝑌|𝑫,𝑯) is the condition mean of 𝑌 given (𝑫,𝑯), 𝛼 are 
coefficients for 𝑫 demographic variables, and 𝛽 are coefficients for the 𝑯 health variables.  The 
goal is the estimate 𝐸(𝑌|𝑫,𝑯), our regression function, in order to predict spending. These 
predictions feed into the determination of the payment the health plan receives in exchange for 
accepting responsibility for paying for the individual’s health care costs. Reasonably accurate 
prediction is necessary to ensure that health plans, many of which are for-profit, will be willing 
to accept and provide good care to enrollees with high costs.   
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 Demographic variables generally take the form of age-sex cell indicator variables. Most 
of the effort in the development of plan payment risk adjustment formulas is associated with the 
creation and selection of the health variables. Thus, as a simplified introductory example, 
stepwise regression in this setting could take the following form: 
1. Start with a baseline formula containing only demographic variables 𝑫: 𝐸(𝑌|𝑫) = 𝛼𝑫. 
2. Assign a rule that will keep added health variables 𝑯 = (𝐻',𝐻(, … ,𝐻/) in the formula if they 
have significant p-values and also increase R2. 
3. Sequentially add health variables 𝑯, beginning with 𝐻', assessing p-values and R2 metrics 
after each addition. 
This illustration could be criticized for many established reasons, including the choice to 
introduce variables one at a time, that it will not evaluate all possible combinations of variables, 
and that we may not end up with an optimal or near-optimal selection of variables in the final 
formula (Mantel 1970; Hocking 1976). We choose to focus on the issue of fairness metrics vs. p-
values and R2 as yet another consideration. 
Although researchers and regulators recognize a number of criteria for inclusion of 
variables in risk adjustment formulas, in practice, the most influential statistical criterion appears 
to be whether a given variable improves performance, as measured by p-value or R2 statistic. 
These metrics are automatically produced by statistical programs (oftentimes without appropriate 
correction for the repeated model fitting), but no metric is automatically generated to capture 
performance in other, potentially more important dimensions. Simply put, using a p-value or R2 
as the statistical criterion to decide variable inclusion in the prediction function can lead to 
mistakes, in the sense that improving fit at the person level may not improve fit in the ways that 
may have even more impact, at the group level. 
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We do not reiterate many of the arguments on the disadvantages of p-values, for example, 
as enumerated in Wasserstein and Lazar (2016).  However, before defining our group-level fit 
metric to evaluate fairness, we do highlight two features of p-values that are particularly relevant 
for stepwise regression building in risk adjustment, which is a high-dimensional prediction 
problem. Firstly, as is well-known, large sample sizes will yield significant p-values for variable 
coefficients that are of trivial magnitude (e.g., Chatfield 1995; van der Laan and Rose 2010).  
Many plan payment risk adjustment formulas are created using millions of observations; 
assessing a variable’s importance for predicting health spending using p-values is effectively 
useless.  The second is regarding the relationship between R2 and p-values. We keep in mind that 
substantial improvements in R2 are accompanied by significant p-values for the added variable, 
but also that miniscule improvements in R2 may result from the addition of a variable with a 
nonsignificant or significant p-value.  
 
3. ADDITIONAL METRICS FOR RISK ADJUSTMENT 
The most important criteria for evaluating a risk adjustment scheme follow from the 
efficiency or fairness problem risk adjustment is trying to fix (Layton et al. 2017).  In the U.S., 
Medicare Advantage (for older and some disabled adults), Medicaid Managed Care (for people 
with lower incomes) and the Marketplaces (for otherwise uninsured, created as part of the 
Affordable Care Act) all operate as individual health insurance markets with competing health 
plans. In these systems, health plans are prohibited by law from discriminating in enrollment or 
services against individuals. For example, plans must accept any individual who applies for 
membership.  However, plans can and do discriminate against groups of individuals, such as 
those with MHSUD, by: (a) limiting provider networks treating this disorder, (b) setting low 
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provider payments to mental health providers to discourage supply, (c) providing less favorable 
coverage of drugs, and other means.  Consequently, individual-level fit is secondary to group-
level fit as a metric for alternative plan payment schemes. 
Group-level fit in U.S. plan payment risk adjustment formulas is often measured by 
predictive ratios, equal to the ratio of predicted values over actual values for a group. A 
predictive ratio less than one indicates that the prediction function underpredicts and will 
therefore underpay for the group. Layton et al. (2017) found that underpayment as measured by 
the predictive ratio in the Marketplaces was most severe for the mental illness group, among the 
four groups they examined. This is concerning because, as noted, although a Marketplace plan 
must accept all applicants, the plan can provide poor care for MHSUD, discouraging individuals 
with these conditions from seeking enrollment in the first place.  
In Europe, it is more common to measure group fit by net compensation, equal to the 
average difference between predicted values for a particular group and actual values:  
Net	Compensation = 	∑ 𝑌ABB∈D𝑛D − ∑ 𝑌BB∈D𝑛D , 
where 𝑌AB is predicted spending for individual i,	𝑌B is observed spending for individual i, and 𝑛D is 
the sample size for the group of interest (Layton et al. 2017). The sums are taken over all 
individuals in the group. Net compensation measures incentives to a plan to provide good service 
to a group. Groups need not be mutually exclusive, and net compensation can be defined with 
respect to each health condition group. We use this fairness metric in our demonstration as it is 
on the same scale as our outcome of interest, and therefore has an easy interpretation.  
Other metrics of health plan performance have been implemented or proposed in the case 
of ensuring equal access to mental health care, but these are recognized as incomplete and of 
doubtful effectiveness as a basis for monitoring plan services (McGuire 2016). While many 
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fairness metrics focus on classification problems, individual vs. group-based notions of fairness 
have been studied (e.g., Zemel et al. 2013; Hu and Chen 2017), as well as general frameworks 
that include non-classification problems (e.g., Kusner et al. 2017). We refer to Mitchell (2017) 
for a didactic summary of fairness metrics in the machine learning and computer science 
literature. 
 
4.     DEMONSTRATION OF THE METRICS 
 
We include an instructive example using the Truven Marketscan data for plan payment risk 
adjustment, which mirrors the approach implemented in the Marketplaces with some 
modification. Plan payment in the Marketplaces is complex, involving adjustments for 
geographic factors and premiums the plans collect from enrollees, among other factors (Layton 
et al. 2018).  At the core of the payment scheme, however, is the Department of Health and 
Human Services Hierarchical Condition Category (HSS-HCC) linear least squares regression 
prediction model, which determines the base payment for each individual (Centers for Medicare 
and Medicaid Services 2016).  
Each HCC variable is the result of a mapping from a subset of the thousands of five-digit 
International Classification of Disease and Related Health Problems (ICD) diagnoses reported on 
claims to a much smaller number of categories.  For example, the HCC for “major depressive, 
bipolar, and paranoid disorders” is generated from over 50 ICD-9 flags. It is important to note 
that not all ICD-9 (or ICD-10, adopted in 2015) codes map to an HCC used for payment. This 
has been shown to be problematic with respect to accurate payments, especially for MHSUD in 
the Marketplaces (Montz et al. 2016). Montz et al. (2016) found systematic underpayment of 
enrollees with MHSUD; 80% of individuals with MHSUD are not recognized by the 
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Marketplace system, contributing to undercompensation for individuals with MHSUD on 
average.  
The HHS-HCC model undergoes regular evaluation, as does its progenitor, the Centers 
for Medicare and Medicaid (CMS) version used for Medicare Advantage, including 
consideration of the HCC diagnostic adjustors.  The HCCs used in the HHS-HCC model are a 
subset of the full 264 HCCs defined in the full system mapping. Adding or subtracting HCCs 
from the right-hand side of the risk adjustment formula is a component in the evaluation of the 
prediction function. Government reports lay out the criteria used in defining HCCs, with the first 
two being the HCC should be “clinically meaningful” and “predictive” (Pope et al. 2004; Ellis et 
al. 2018).  Other risk adjustment formulas consider additional variable types for special 
populations, such as measures of functional status in the CMS frailty model (Kautter and Pope 
2004).  
Our Marketscan sample contained all those continuously enrolled from January 2015 to 
December 2016 who had prescription drug coverage and mental health coverage. We excluded 
enrollees with missing geographic region or claims information, as well as those with negative 
claims. With these restrictions, we took a sample of 4,000,000 enrollees that we used in our 
analysis. The outcome, total annual expenditures in 2016, was calculated by summing all 
inpatient, outpatient, and drug payments.  Mean total spending for an individual adult was 
$6,619. 
The baseline formula included 75 HCCs from 2015, as well as age and sex, as predictor 
variables in a main terms parametric regression. We additionally considered two mental health 
HCCs and two substance use disorder HCCs. These 79 HCCs followed the CMS-HCC risk 
adjustment formula in place for Medicare Advantage (Pope et al. 2011). We defined the 
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MHSUD group for calculation of net compensation using Clinical Classification Software (CCS) 
categories, a more comprehensive set of variables compared to the HCCs. Each ICD flag maps to 
a CCS category, unlike the mapping from ICD to HCC described above. Therefore, our 
calculation of net compensation will capture the impact of the risk adjustment formula for those 
with MHSUD recognized and unrecognized by the formula. (We emphasize here that individuals 
with MHSUD but no MHSUD ICD flags will not be captured by HCCs or CCS categories.) The 
MHSUD group contains 13.8% of the sample, compared to the 2.6% of the sample identified 
using the four HCCs. Mean total spending for an individual in the MHSUD group was $11,346, 
which was 71% higher than mean spending for an individual in the total sample. 
We describe possible iterative stepwise regression decision-making processes in Figure 1, 
guided by different metrics (that could be defined a priori and within cross-validation, e.g., to try 
to avoid cherry picking and overfitting). As noted earlier, with a sample size of four million 
enrollees, p-values are a largely ineffective metric. All but three variables in the baseline formula 
were significant, even those with small event rates, such as “pressure ulcer of the skin, with 
necrosis through to muscle, tendon, bone” with 109 enrollees. The most prevalent HCC was 
“diabetes without complications,” occurring among 5.0% of individuals in the sample. This 
baseline formula had an adjusted R2 of 13.1%, which is similar to the 12% R2 typically achieved 
with the same specification in Medicare. Net compensation for MHSUD was a nontrivial 
underpayment, reflected in the negative value -$2,822, which was 25% of the mean total 
spending in the MHSUD group. Therefore, enrollees with MHSUD are vastly underpaid relative 
to those without MHSUD, giving insurers a strong incentive to distort their plan offerings to 
avoid these enrollees. 
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Figure 1. Decision-Making Flow Chart for Plan Payment Formula with Differing Metrics 
 
A stepwise regression formula building exercise that aims to maximize R2 or optimize 
MHSUD net compensation toward zero might proceed from the baseline formula (formula 1 in 
Figure 1) to formula 2, which added two mental health HCCs (“schizophrenia” and “major 
depressive, bipolar, and paranoid disorders”). This provided a small 2% increase in R2 but a 31% 
increase in MHSUD net compensation; p-values for both variables were statistically significant. 
Because MHSUD net compensation calculated based on formula 1 was a large negative number, 
increases in MHSUD net compensation that did not lead to a value greater than zero were 
 12 
improvements. Moving from formula 2 to formula 3, we added two substance use HCCs 
(“drug/alcohol psychosis” and “drug/alcohol dependence”). The R2 did not change; a stepwise 
regression maximizing based on R2 (and parsimony) would revert back to formula 2. However, 
there was a continued increase in MHSUD net compensation (this time of 11%), thus a stepwise 
regression optimizing this metric would keep formula 3 and continue. 
Moving from formula 3, which contained the complete set of 79 HCCs used in the Medicare 
Advantage risk adjustment formula, the stepwise regression might then consider deletion steps of 
statistically significant variables to improve fit and fairness. Formula 4a removed the HCCs 
associated with liver conditions with no impact on R2, but a 2% decrease in MHSUD net 
compensation (a movement in the wrong direction). A stepwise regression driven by R2 and 
parsimony would prefer such a formula, despite being worse than formula 3 for MHSUD net 
compensation (and likely worse for those with liver conditions). An alternative deletion step 
from formula 3 might be to remove kidney condition HCCs, represented in formula 4b. Here, R2 
dropped by 18%, yet MHSUD net compensation improved by 2%, and was indeed the best 
MHSUD net compensation of all the formulas in Figure 1. A stepwise regression that is 
searching based solely on improving MHSUD net compensation selects formula 4b, despite its 
overall poorer global fit (as assessed by R2) and impact on those with kidney conditions. 
 
5.    DISCUSSION 
Beyond the well-known drawbacks of stepwise regression procedures, building an 
“appropriate” stepwise risk adjustment formula in a policy environment is not as simple as 
defining overall fit metrics for evaluation. Overreliance on statistical measures of global fit, such 
as p-values and R2, in observational individual-level data does not consider the inequalities 
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created or exacerbated in potentially vulnerable groups.  Fair formulas are especially critical in 
healthcare systems where risk adjustment may have a direct or indirect impact on human health. 
In this context, p-values and R2 may not be “morally neutral,” to quote Professor Unsworth’s use 
of this phrase for the subjectivity and ethics of statistical algorithms (Reyes 2016).  
The massive size of the health care sector in the U.S. and its salience for personal and 
social welfare make risk adjustment arguably one of the most consequential applications of 
stepwise regression for social policy.  As another example, valid evaluation of the relative 
performance of hospitals with respect to quality and outcomes requires risk adjustment for the 
health of each hospital’s patient population, often referred to as “case-mix” (Shahian and 
Normand 2008). Hospitals with sicker patients along dimensions not included in the risk 
adjustment formula will perform poorly in these assessments, leading to payment sanctions in 
public health insurance programs and possible closure by state regulators. Some approaches to 
case-mix adjustment for hospital quality explicitly use p-values to select variables in more 
parsimonious models (e.g., O’Malley et al. 2005). 
We argue that there is a pressing need to consider a formal ensemble of metrics for 
evaluation of plan payment risk adjustment that balances both global fit and multiple fairness 
metrics. This is a likely scenario in other applied settings. It is well-accepted that evaluation of 
risk adjusted models for plan payment involves numerous criteria. While regulators can and do 
make good faith efforts to examine vulnerable groups using predictive ratios and other measures 
(Layton et al. 2016), most of these procedures are ad hoc. Our stepwise regression risk 
adjustment demonstration represented a simplification of a deeply difficult policy problem and 
considered only one vulnerable group – those with MHSUD. Even in this simplified example 
with only one fairness metric, the “best” MHSUD net compensation was still a large 
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underpayment relative to mean total spending, further highlighting the challenge of deploying a 
more comprehensive system with multiple groups. While unlikely to solve the totality of the 
fairness issues plaguing plan payment risk adjustment, there are numerous planned changes for 
the 2019 Medicare Advantage plan payment risk adjustment formula, including adding 
additional MHSUD HCCs (Centers for Medicare & Medicaid Services 2017). Fairness will also 
not be addressed by simply using machine learning rather than stepwise regression to estimate 
the risk adjustment formula or perform variable selection (e.g., Rose 2016; Shrestha et al. 2017) 
if standard statistical fit metrics are still the basis of evaluation for those tools.  
The fairness issues facing plan payment risk adjustment are not entirely unique given the 
pervasive use of stepwise regressions and similar tools in many applications. Consideration of 
what makes a formula fair for the lives these health care algorithms touch has thus far been 
comparatively underdeveloped. Important work has been done in the areas of predictive policing 
(e.g., Lum and Isaac 2016), recidivism (e.g., Chouldechova 2017), and hospital ratings (e.g., 
Phillips 2018), for example. Leveraging and adapting these vital advances while expanding 
fairness approaches for the distinctive needs of health plan payment is a crucial issue moving 
forward. The Association for Computing Machinery recently issued a statement on automated 
decision-making describing seven principles for algorithmic transparency and accountability: 
awareness, access and redress, responsibility, explanation, data provenance, auditability, and 
validation and testing (Association for Computing Machinery 2017). It will be especially fruitful 
to bring these principles to bear in a context where the algorithms have a real impact on the 
welfare of vulnerable groups in the health care system. 
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